期刊文献+

5-BrdU标记骨髓间充质干细胞修复椎间盘退变中的示踪研究 被引量:2

Tracing study of 5-BrdU labeled MSCs in treating degenerative discs
原文传递
导出
摘要 目的:探讨5-溴脱氧尿嘧啶(5-BrdU)示踪时效及5-BrdU标记的骨髓间充质干细胞(BMSCs)在移植椎间盘后存活及细胞增殖情况。方法:分离、培养并鉴定兔BMSCs;使用模拟人后外侧入路针吸髓核法建立兔的椎间盘退变模型;注入经5-BrdU标记的骨髓间充质干细胞,在移植后第2、4、8、12周观察MSCs的增殖情况及5-BrdU示踪情况。结果:经体外标记的5-溴脱氧尿嘧啶标记率>90%;BrdU标记的BMSC移植于退变的椎间盘2周、4周、8周和12周后,在实验椎间盘内均可见BrdU染色的阳性细胞,随着时间推移,阳性细胞逐渐增多,且排列逐渐规则。结论:5-BrdU完全能够满足移植细胞的标记需要。5-BrdU标记的骨髓间充质干细胞能在所移植的椎间盘内存活及增殖。 Objective:To evaluate the tracing efficacy of 5-BrdU and the proliferation of the 5-BrdU labeled bone marrow mesenchymal stem cells (MSCs) which was transplanted to treat the degenerative intervertebral discs. Methods: After the isolation,culture and identification of the rabbit BMSCs which was labeled by 5-BrdU, it was transplanted to the rabbit model established by aspiration of the nucleus pulposus. 2,4 , 8 and 12 weeks later , immunohistology was used to evaluate the proliferation of MSCs and the tracing efficacy of 5-BrdU. Result: Labeled in vitro, the labelling rate of 5-BrdU was over 90~. The labeled bone marrow mesenchymal stem cells sustained until the 12th week. The number of positive cells in- creased with time,and gradually the cells arrange in regular manner. Conclusion:5-BrdU labeled bone marrow mesenchymal stem cells can proliferate in the degenerative discs and 5-BrdU can be used to trace the transplanted MSCs completely.
出处 《中国中医骨伤科杂志》 CAS 2013年第1期4-7,共4页 Chinese Journal of Traditional Medical Traumatology & Orthopedics
关键词 椎间盘退变 骨髓间充质干细胞 移植 示踪 Intervertebral Disc Degeneration Bone Marrow Mesenchymal Stem Cells Transplant Tracing
  • 相关文献

参考文献17

  • 1DEANS R J, MOSELEY A B. Mesenchymal stem cells: Biology and potential clinical uses[J]. Exp hematol,2000,28(8):875-878.
  • 2YOO J U, MANDELL I, ANGELE P, et al. Chondlogenitor cells and gene therapy[J]. Clin Orthop,2000,379(Suppl):164-170.
  • 3MOUTSATSOS I K, TURGEMAN G, ZHOU S, et al. Exogenously regulated stem cell-mediated gene therapy for bone regeneration[J]. Mol Ther, 2001, 3(4):449-461.
  • 4MARX J C, ALLAY J A, PERSONS D A, et al. High-efficiency transduction and long-term gene expression with a routine stem cell retroviral vector encoding the green fluorescentprotein in human marrow stromal cells[J]. Hum Gene The, 1999, 10(7): 1163-1173.
  • 5PITTENGER M F, MACKAY A M, BECK S C, et al. Multilin- eage potential of adult human mesenchymal stem cells[J]. Science, 1999, 284(5411):143-147.
  • 6SIKAVITSAS V I,BANCROFT G N,MIKOS A G, Formation of three-dimensional cell/polymer constructs for bone tissue engineering in a spinner flask and a rotating wall vessel bioreactor[J]. J Biomed Mater Res,2002,62(1):136-148.
  • 7KOC O N, LAZARUS H M. Mesenchymal stem cells [J]. Bone Marrow Transplant, 2001,27 (3) : 235-239.
  • 8MINGUELL J J, ERICES A, CONGET P. Mesenehymal stem cells [J]. Exp Biol Med ,2001,226(6) :507-520.
  • 9YAMAMOTO Y,MOCHIDA J,SAKAI D, et al. Reinsertion of nucleus pulposus cells activated by mesenchymal stem cells using cocuhuremethod decelerated intervertebral disc degeneration[J]. Spine, 2003,3 : 101-102.
  • 10SOBAJIMA S, VADALA G, SHIMER A, et al. Feasibility of stem cell therapy for intervertebral disc degeneration[J]. Spine, 2004,4 : 117.

同被引文献37

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部